… attention deficit hyperactivity disorder medicine use in Australia, especially among young
females. Nevertheless, treatment … that the prevalence of pharmacological treatment of ADHD …

… medication exposure through the nationwide prescription … We considered several demographic
and clinical factors in our … We pooled data from Finland, Iceland, Norway and Sweden …

… was used to build the study population and to identify other … In addition, although
pharmacological treatment in our study … Similar to a register-based study from Sweden, 10 we …

… Sweden and Italy also had the lowest and highest BT utilization prior to starting medication
(… NICEAttention deficit hyperactivity disorder: diagnosis and managementNational clinical …

… demographic characteristics, socio-occupational status, social relationships, clinical variables
of the disease, and pharmacological and non-pharmacological … pharmacological treatment …

… All demographic and health data were collected by the Swedish … or prescription of ADHD
medication in the PDR. According to the treatment recommendations from the Swedish Medical …

… drugs in Sweden, … Swedish population aged 16 or older since 1990. The Multi-Generation
Register (MGR) 38 provides information on biological relationships for all residents in Sweden …

… individuals with an attention deficit hyperactivity disorder (ADHD) … pharmacological treatment
for attention deficit hyperactivity … in relation to sociodemographic and clinical characteristics. …

… disorder compared with the general population. The management of attentiondeficit hyperactivity
disorder … regard to attention deficit hyperactivity disorder (ADHD) in children and adults. …

… to be similar enough in terms of patient characteristics, setting and outcome definitions, …
descriptive statistics for trial and study population characteristics across all eligible trials. We will …